Development and validation of a mathematical algorithm for quantifying preoperative blood volume by means of the decrease in hematocrit resulting from acute normovolemic hemodilution

Transfusion

Volumn 45, Issue 4, 2005, Pages 562-571

  Jacob, Matthias ^a   Bruegger, Dirk ^b   Conzen, Peter ^b   Becker, Bernhard Friedrich ^b   Finsterer, Udilo ^b   Rehm, Markus ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; ERYTHROCYTE VOLUME; HEMATOCRIT; HEMODILUTION; HUMAN; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; VALIDATION PROCESS;

ALGORITHMS; BLOOD VOLUME DETERMINATION; HEMATOCRIT; HEMODILUTION; HUMANS; MODELS, BIOLOGICAL; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 17044374396     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04292.x     Document Type: Article

References (37)

1. Atallah MM, Banoub SM, Saied MM. Does timing of hemodilution influence the stress response and overall outcome? Anesth Analg 1993;76:113-7.
2. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74:315-9.
3. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.
4. Carson JL, Duff A, Poses RM, et al. Effect of anemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-60.
5. Heiss MM. Risk of allogeneic transfusions. Br J Anaesth 1998;81(Suppl 1):16-9.
6. Herbert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997;155:1618-23.
7. Ickx BE, Rigolet M, Van der Linden PJ. Cardiovascular and metabolic response to acute normovolemic anemia: effects of anesthesia. Anesthesiology 2000;93:1011-6.
8. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusion. Transfusion 1991;31:212-7.
9. Van der Linden P, Wathieu M, Gilbart E, et al. Cardiovascular effects of moderate normovolemic hemodilution during enflurane-nitrous oxide anaesthesia in man. Acta Anesthesiol Scand 1994;38:490-8.
10. Weiskopf RB. More on the changing indications for transfusion of blood and blood components during anesthesia [editorial]. Anesthesiology 1996;84:498-501.
11. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998;86:9-15.
12. Kreimeier U, Messmer K. Hemodilution in clinical surgery: state of the art 1996. World J Surg 1996;20:1208-17.
13. Jamnicki M, Kocian R, Van der Linden P, Zaugg M, Spann DR. Acute normovolemic hemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 2003;17:747-54.
14. Napier JA, Bruce M, Chapman J, et al. Guidelines for autologous transfusion. H. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology Blood Transfusion Task Force. Autologous Transfusion Working Party. Br J Anaesth 1997;78:768-71.
15. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994;34:176-9.
16. Weiskopf RB. Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 1995;35:37-41.
17. Weiskopf KB. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 2001;94:439-46.
18. Matot I, Scheinin O, Jurim O, Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002;97:794-800.
19. Weiskopf RB. Hemodilution and candles [editorial]. Anesthesiology 2002;97:773-5.
20. Rehm M, Haller M, Orth VH, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001;95:849-56.
21. Rehm M, Orth VH, Kreimeier U, et al. Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology 2000;92:657-64.
22. Haller M, Dressel H, Thiel M, et al. Determination of red-cell volume with a nonradioactive marker (sodium fluorescein) in humans using flow cytometry. Infusionsther Transfusionsmed 1997;24:132-7.
23. Pearson TC, Guthrie DL, Simpson J, et al. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 1995;89:748-56.
24. Haller M, Brechtelsbauer H, Finsterer U, et al. The determination of plasma volume using indocyanine green in man. Anaesthesist 1992;41:115-20.
25. Rehm M, Haller M, Brechtelsbauer H, Akbulut C, Finsterer U. Changes in plasma volume in immediate pre- and postoperative periods in patients with major gynecologic surgery. Infusionsther Transfusionsmed 1998;25:222-8.
26. Bourke DL, Smith TC. Estimating allowable hemodilution. Anesthesiology 1974;41:609-12.
27. Rehm M, Orth VH, Kreimeier U, et al. Changes in blood volume during acute normovolemic hemodilution with 5% albumin or 6% hydroxyethylstarch and intraoperative retransfusion. Anaesthesist 2001;50:569-79.
28. Orth VH, Rehm M, Thiel M, et al. First clinical implications of perioperative red cell volume measurement with a nonradioactive marker (sodium fluorescein). Anesth Analg 1998;87:1234-8.
29. Price DC, Swann SJ, Hung ST, et al. The measurement of circulating red cell volume using nonradioactive cesium and fluorescent excitation analysis. L Lab Clin Med 1976;87:535-43.
30. Gehan EA, George SL. Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970;54:225-35.
31. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leucocytes within mammalian capillaries. Circ Res 1996;79:581-9.
32. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflügers Arch Eur J Physiol 2000;440:653-66.
33. Jacob M, Rehm M, Orth V, et al. Exact measurement of the Volume effect of 6% hydroxyethyl starch 130/0.4 (Voluven®) during acute preoperative normovolemic hemodilution. Anaesthesist 2003;52:896-904.
34. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001;95:849-56.
35. Brulisauer M, Bollinger A. Measurement of different human microvascular dimensions by combination of videomicroscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp 1991;10:21-31.
36. Jones JG, Holland BM, Hudson IR, Wardrop CA. Total circulating red cells versus haematocrit as the primary descriptor of oxygen transport by the blood. Br J Haematol 1990;76:288-94.
37. Bentley SA, Lewis SM. The relationship between total red cell volume, plasma volume and venous hematocrit. Br J Haematol 1976;33:301-7.